V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10350156 | 10056520 | 1.6 | 72.8 | Palliative (P) | 2018-08-04 | 2019-03-20 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 101707494 |
| 10350641 | 10056522 | 1.51 | 58.5 | Curative (C) | 2018-10-26 | 2018-11-05 | CTD Attenuated (Thalidomide 50mg) | 02 | N | VINORELBINE | 100507959 |
| 10351550 | 10056525 | 1.76 | 106.6 | Palliative (P) | 2022-03-17 | 2022-04-14 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100945888 |
| 10351668 | 10056526 | 0 | 62 | 03 | null | 2021-06-29 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | CYCLOPHOSPHAMIDE | 101191506 |
| 10352108 | 10056527 | 0 | 78.6 | Curative (C) | 2022-04-24 | 2022-05-08 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101438855 |
| 10354576 | 10056530 | 1.79 | 70.3 | null | 2017-05-03 | 2017-08-28 | Chlorambucil | 02 | null | CHLORAMBUCIL | 101148300 |
| 10354581 | 10056531 | 1.74 | 73.1 | Palliative (P) | null | 2018-04-14 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100820369 |
| 10354777 | 10056532 | 1.84 | null | null | null | 2021-03-31 | GEMCITABINE | 02 | null | GEMCITABINE | 100516461 |
| 10355267 | 10056533 | 1.76 | 93.9 | null | 2018-10-28 | 2018-11-11 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101637425 |
| 10355560 | 10056534 | 1.87 | 63.5 | null | 2021-11-11 | 2021-12-06 | Bortezomib (weekly) | 02 | null | BORTEZOMIB | 101498072 |
| 10355693 | 10056535 | 1.72 | 109.7 | Palliative (P) | 2019-11-27 | 2019-12-11 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100860209 |
| 10355992 | 10056536 | 1.55 | 76.4 | Curative (C) | 2018-09-14 | 2018-09-23 | CETUXIMAB | 02 | N | BUSULFAN | 101302707 |
| 10356165 | 10056537 | 1.77 | 40.3 | null | 2020-03-08 | 2020-03-10 | Cyclophosphamide oral | N | null | CYCLOPHOSPHAMIDE | 100424467 |
| 10356446 | 10056538 | 0 | 75 | null | null | 2018-07-23 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101175884 |
| 10356697 | 10056539 | 1.7 | 96.2 | null | 2020-08-01 | 2020-08-16 | MELPHALAN | 02 | null | MELPHALAN | 101738276 |
| 10357265 | 10056541 | 1.7 | 68.9 | Adjuvant (A) | 2018-02-25 | 2018-03-05 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100356773 |
| 10357955 | 10056543 | 1.68 | 62.6 | 03 | 2020-03-31 | 2020-03-31 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100153601 |
| 10358064 | 10056544 | 1.94 | 94.8 | 03 | null | 2022-05-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100174210 |
| 10358543 | 10056545 | null | 60.4 | 03 | 2019-02-17 | 2019-05-25 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100778465 |
| 10359193 | 10056548 | 1.48 | 61.8 | null | 2022-01-13 | 2022-01-23 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 100567201 |
| 10359234 | 10056549 | 1.8 | 84 | Palliative (P) | 2018-12-22 | 2019-03-14 | Melphalan IV High dose | 02 | N | MELPHALAN | 100270520 |
| 10359341 | 10056550 | 1.58 | 75 | 03 | 2022-01-03 | 2022-01-12 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 101705819 |
| 10359394 | 10056551 | 1.71 | 77.8 | null | null | 2017-03-29 | CABOZANTINIB | 02 | null | CETUXIMAB | 100636537 |
| 10361328 | 10056553 | 1.63 | 66.8 | Palliative (P) | null | 2022-04-21 | Melphalan IV High dose | 02 | N | MELPHALAN | 100029162 |
| 10361548 | 10056554 | 1.86 | 81 | Palliative (P) | 2020-09-28 | 2021-11-24 | Cabazitaxel | 02 | null | CABAZITAXEL | 100295419 |
| 10362620 | 10056556 | 1.67 | 59 | 03 | null | 2019-01-26 | BORTEZOMIB + THALIDOMIDE | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101770265 |
| 10362682 | 10056557 | 0 | null | 03 | 2019-03-03 | 2022-01-08 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100323336 |
| 10362688 | 10056558 | null | 61.7 | null | 2016-10-25 | 2017-01-09 | Niraparib | 02 | null | FLUOROURACIL | 100170131 |
| 10363578 | 10056559 | null | 68.5 | Curative (C) | 2019-02-13 | 2019-02-21 | IPILIMUMAB + NIVOLUMAB | 02 | N | CISPLATIN + GEMCITABINE | 100493434 |
| 10363855 | 10056560 | 1.72 | 71 | Palliative (P) | null | 2021-11-22 | GEMCITABINE | 02 | N | GEMCITABINE | 101583433 |
| 10364425 | 10056563 | 1.66 | 64.2 | null | 2020-01-16 | 2020-01-18 | Gemcitabine weekly | 02 | null | GEMCITABINE | 101607319 |
| 10364497 | 10056564 | 1.71 | 89.9 | Palliative (P) | null | 2020-01-31 | Palbociclib | 02 | N | PALBOCICLIB | 101325769 |
| 10364764 | 10056565 | 1.78 | null | null | 2018-07-25 | 2018-07-25 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | null | CAPECITABINE + IRINOTECAN | 101416604 |
| 10364923 | 10056566 | 1.59 | 70 | null | 2020-09-15 | 2021-04-10 | BORTEZOMIB + THALIDOMIDE | 02 | null | ACALABRUTINIB | 100868919 |
| 10364994 | 10056567 | 1.72 | 71 | null | 2013-07-20 | 2020-04-17 | CABOZANTINIB | 02 | null | CETUXIMAB | 100866053 |
| 10365670 | 10056570 | 1.68 | 63.2 | null | null | 2021-09-10 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101222193 |
| 10365874 | 10056571 | 1.85 | 61.1 | 03 | 2020-01-29 | 2020-03-11 | MELPHALAN | 02 | N | MELPHALAN | 101308898 |
| 10365901 | 10056572 | 1.72 | 55 | null | 2019-08-27 | 2019-08-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100204129 |
| 10365977 | 10056573 | 1.85 | 67.65 | null | 2022-01-30 | 2022-01-30 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 101150206 |
| 10367063 | 10056575 | 1.67 | 70.3 | Palliative (P) | 2020-05-11 | 2020-05-29 | Cabazitaxel | 99 | N | CABAZITAXEL | 100261662 |
| 10367828 | 10056579 | 1.69 | null | null | 2019-12-07 | 2019-12-07 | Azacitidine | null | null | AZACITIDINE | 101414832 |
| 10367882 | 10056581 | 1.69 | 84 | null | null | 2020-05-20 | Cyclophosphamide Weekly PO | 2 | null | CYCLOPHOSPHAMIDE | 100594389 |
| 10368044 | 10056582 | 1.64 | 75 | null | 2019-05-21 | 2019-09-08 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | null | null | CISPLATIN + GEMCITABINE | 100186007 |
| 10368054 | 10056583 | 1.45 | 76 | null | 2016-02-11 | 2016-02-27 | Niraparib | 01 | null | CETUXIMAB | 100298284 |
| 10368225 | 10056586 | 1.67 | 63.15 | Palliative (P) | 2019-09-15 | 2019-10-04 | Acalabrutinib | N | N | CISPLATIN + GEMCITABINE | 100162808 |
| 10368278 | 10056587 | 1.56 | 59.95 | Palliative (P) | null | 2021-07-23 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 100223058 |
| 10368315 | 10056588 | 1.75 | 51.7 | 03 | null | null | CETUXIMAB + IRINOTECAN + MDG | 02 | N | VINORELBINE | 100683518 |
| 10368556 | 10056591 | 1.7 | 68.8 | 03 | 2019-12-23 | 2019-12-27 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100653178 |
| 10368732 | 10056592 | 0 | 82 | null | 2017-10-11 | 2017-10-12 | AFATINIB | 02 | null | AFATINIB | 101662816 |
| 10368801 | 10056594 | 1.73 | 152 | Palliative (P) | 2019-05-13 | 2019-05-20 | CYCLOPHOSPHAMIDE + MESNA | 02 | null | CYCLOPHOSPHAMIDE | 101799038 |